Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify su...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-04-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558605800727 |
id |
doaj-5403deea7e904aeaa8eafff5a39a4e53 |
---|---|
record_format |
Article |
spelling |
doaj-5403deea7e904aeaa8eafff5a39a4e532020-11-25T00:36:36ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022005-04-017440741610.1593/neo.04715Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated AdenocarcinomasCharles A. Fox0Lisa M. Sapinoso1Hong Zhang2Wanghai Zhang3Howard L. McLeod4Gina R. Petroni5Tarun Mullick6Christopher A. Moskaluk7Henry F. Frierson8Garret M. Hampton9Steven M. Powell10Digestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USAGenomics Institute of the Novartis Research Foundation, San Diego, CA, USADepartment of Pathology, Anhui Medical University, Hefei, Anhui, ChinaDepartment of Medicine, Molecular Biology, Pharmacology, and Genetics, Washington University, St. Louis, MO, USADepartment of Medicine, Molecular Biology, Pharmacology, and Genetics, Washington University, St. Louis, MO, USAHealth Evaluation Sciences, University of Virginia, Charlottesville, VA, USADigestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USADepartment of Pathology, University of Virginia, Charlottesville, VA, USADepartment of Pathology, University of Virginia, Charlottesville, VA, USAGenomics Institute of the Novartis Research Foundation, San Diego, CA, USADigestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify such potential biomarkers. Over 22,000 genes were analyzed by oligonucleotide microarrays on 38 unique RNA. Unsupervised and supervised clusterings were performed on a subset of 2849 genes that varied most significantly across the specimens. Unsupervised clustering identified two discernable molecular BE profiles, one of which was similar to normal gastric tissue (“BE1”), and another that was shared by several of the AC specimens (“BE2”). The BE1 profile included expression of several genes that have been described as tumor-suppressor genes, most notably trefoil factor 1 (TFF-1). The BE2 profile included expression of genes previously found overexpressed in cancers, such as carboxylesterase-2 (CES-2). IHC demonstrated the loss of TFF-1 late in the progression of BE to AC. It also revealed CES-2 as being upregulated in AC documented to have arisen in the presence of BE. These potential biomarkers, as well as the relative expression of genes from BE1 versus those from BE2, may be validated in the future to aid in risk stratification and guide treatment protocols in patients with BE and associated AC. http://www.sciencedirect.com/science/article/pii/S1476558605800727Trefoil Factor 1Carboxylesterase 2Barrett's esophagusesophageal or gastric adenocarcinomatissue microarry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Charles A. Fox Lisa M. Sapinoso Hong Zhang Wanghai Zhang Howard L. McLeod Gina R. Petroni Tarun Mullick Christopher A. Moskaluk Henry F. Frierson Garret M. Hampton Steven M. Powell |
spellingShingle |
Charles A. Fox Lisa M. Sapinoso Hong Zhang Wanghai Zhang Howard L. McLeod Gina R. Petroni Tarun Mullick Christopher A. Moskaluk Henry F. Frierson Garret M. Hampton Steven M. Powell Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas Neoplasia: An International Journal for Oncology Research Trefoil Factor 1 Carboxylesterase 2 Barrett's esophagus esophageal or gastric adenocarcinoma tissue microarry |
author_facet |
Charles A. Fox Lisa M. Sapinoso Hong Zhang Wanghai Zhang Howard L. McLeod Gina R. Petroni Tarun Mullick Christopher A. Moskaluk Henry F. Frierson Garret M. Hampton Steven M. Powell |
author_sort |
Charles A. Fox |
title |
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas |
title_short |
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas |
title_full |
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas |
title_fullStr |
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas |
title_full_unstemmed |
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas |
title_sort |
altered expression of tff-1 and ces-2 in barrett's esophagus and associated adenocarcinomas |
publisher |
Elsevier |
series |
Neoplasia: An International Journal for Oncology Research |
issn |
1476-5586 1522-8002 |
publishDate |
2005-04-01 |
description |
Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify such potential biomarkers. Over 22,000 genes were analyzed by oligonucleotide microarrays on 38 unique RNA. Unsupervised and supervised clusterings were performed on a subset of 2849 genes that varied most significantly across the specimens. Unsupervised clustering identified two discernable molecular BE profiles, one of which was similar to normal gastric tissue (“BE1”), and another that was shared by several of the AC specimens (“BE2”). The BE1 profile included expression of several genes that have been described as tumor-suppressor genes, most notably trefoil factor 1 (TFF-1). The BE2 profile included expression of genes previously found overexpressed in cancers, such as carboxylesterase-2 (CES-2). IHC demonstrated the loss of TFF-1 late in the progression of BE to AC. It also revealed CES-2 as being upregulated in AC documented to have arisen in the presence of BE. These potential biomarkers, as well as the relative expression of genes from BE1 versus those from BE2, may be validated in the future to aid in risk stratification and guide treatment protocols in patients with BE and associated AC.
|
topic |
Trefoil Factor 1 Carboxylesterase 2 Barrett's esophagus esophageal or gastric adenocarcinoma tissue microarry |
url |
http://www.sciencedirect.com/science/article/pii/S1476558605800727 |
work_keys_str_mv |
AT charlesafox alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT lisamsapinoso alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT hongzhang alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT wanghaizhang alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT howardlmcleod alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT ginarpetroni alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT tarunmullick alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT christopheramoskaluk alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT henryffrierson alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT garretmhampton alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas AT stevenmpowell alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas |
_version_ |
1725304584617852928 |